Completed PHASE3 INTERVENTIONAL 2-arm NCT05099055

Dexmedetomine as Adjuvant for Spinal Anesthesia in Elective Cesarian Sections : a Pilot Study

Dexmedetomidine Comme Adjuvant à la rachianesthésie Lors de césariennes électives : Une étude Pilote

Sponsor: St. Justine's Hospital

Conditions Analgesia Analgesia, Obstetrical Analgesics, Non-Narcotic Analgesics, Opioid Anesthesia, Obstetrical Anesthesia, Spinal Dexmedetomidine

Interventions Dexmedetomidine 0.004 MG/ML [Precedex] Opioids

Updated 7 times since 2021 Last updated: May 8, 2023 Started: Mar 15, 2022 Primary completion: Jan 20, 2023 Completion: May 5, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Analgesia and Analgesia, Obstetrical and is currently completed. St. Justine's Hospital leads this study, which shows 7 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jun 2023 — Jul 2024 [monthly]

Completed PHASE3

Status: Recruiting → Completed
Nov 2022 — Jun 2023 [monthly]

Recruiting PHASE3
Jun 2022 — Nov 2022 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

Apr 2022 — Jun 2022 [monthly]

Not Yet Recruiting PHASE3
Nov 2021 — Apr 2022 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

St. Justine's Hospital

Data source: St. Justine's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada